Login to Your Account

MorphoSys Backs Dutch Firm Lanthio in $6M Series A Round

By Cormac Sheridan
Staff Writer

Tuesday, November 27, 2012
Lanthio Pharma BV found an influential backer for its peptide technology in the shape of antibody developer MorphoSys AG, which has participated in its €4.8 million (US$6.2 million) Series A round and which will help it to develop and commercialize its LanthioPep platform.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription